PrintThe Burrill Report
The Burrill Report (August 4, 2014): Broadening the Omics to Personalize Cancer Therapy
The decision-making process for cancer treatments is growing more sophisticated with the broadening of data used to determine the best course of treatment for an individual patient. Perthera, a precision cancer therapy company, is leveraging recent scientific breakthroughs to perform a complete molecular analysis of a patient’s cancer to determine the best therapies and drug trials to treat each patient’s unique cancer. We spoke to Dendy Young, chairman of Perthera, about the company, the benefits of looking beyond the genetics of tumors to determine the course of treatment to use for a patient, and whether these personalized medicine approaches in cancer will take hold in other disease areas.
July 31, 2014
http://www.burrillreport.com/article-broadening_the_omics_to_personalize_cancer_therapy.html
PERSONALIZED MEDICINE
Broadening the Omics to Personalize Cancer Therapy
Podcast: August 4, 2014[Please login to post comments]
- Biotech Industry Shatters Fundraising Records in 2014
Ongoing fight over drug pricing overshadows industry in the new year Read More - G. Steven Burrill Issues Annual Predictions for the Biotechnology Industry
Focus to shift from promise to execution in 2015 Read More - Actavis’ $66B Purchase of Allergan Continues Record Year of M&A; Transactions for Life Sciences
Increasingly Competitive Environment for Sought-After Assets Pushes Prices Higher, Says Burrill Media. Read More - AbbVie Terminates Shire Acquisition, But M&A; Activity Remains Brisk
Total life sciences transactions through first 10 months of 2014 reach $253.3 Billion, says Burrill Media Read More - U.S. Government’s Effort to Quell Tax-Driven Acquisitions Could Slow Life Sciences Dealmaking
Nearly half of dollar volume of M&A; activity in 2014 involved inversions, says Burrill Media Read More - Life Sciences M&A; Activity Sets Annual Record with $8.3B Roche Agreement to buy Intermune, Burrill Media Reports
Press Release Read More - Fitness and Personal Health Apps Could Pose Privacy Nightmare
Senator Schumer says patients’ data could be sold to third parties without their knowledge. Read More - Intel and Fox Foundation Team to Use Smartwatches to Track Parkinson's Patients
Data from wearable devices has potential to improve monitoring and treatment. Read More - Otonomy Raises $100M in Upsized IPO
Seventy-seven life sciences companies raised $5.8 billion through IPOs by mid-August. Read More - Payers Look to Curb Spending on Specialty Drugs
Podcast: August 18, 2014 Read More
